Biotech startups that raised Series B in Washington, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| InduPro | Seattle | Series B | $77.0M | 2026-08-12 |
| Curi Bio | Seattle | Series B | $10.0M | 2025-12-02 |
| Outpace Bio | Seattle | Series B | $144.0M | 2024-08-01 |
| ProfoundBio | Seattle | Series B | $112.0M | 2024-02-13 |
| Proniras | Seattle | Series B | $4.7M | 2024-02-01 |
| Pattern Computer | Friday Harbor | Series B | $1.8M | 2022-02-09 |
| Phytelligence | Seattle | Series B | $9.8M | 2018-07-09 |
7 rows of the CSV in 5 of its 18 columns.
- The 28 biotech startups in Washington, United States whose last round is Series B have raised $2.0B in total.
- 2 of them closed their most recent round in the last 12 months, $87.0M combined.
- The largest of those rounds is InduPro's $77.0M Series B, dated August 2026.
- RA Capital Management is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 26 companies (93%).
- 7% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
2 of 28| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| InduPro | InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. | Biotech | Seattle | Series B | $77.0M | 2026-08-12 | $162.0M | Euclidean Capital, The Column Group, Vida Ventures +1 | 51 to 100 | 2022 |
| Curi Bio | Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. | Artificial intelligence | Seattle | Series B | $10.0M | 2025-12-02 | $30.4M | National Institutes of Health, Dynamk Capital | 11 to 50 | 2015 |
Table 1. Biotech startups that raised Series B in Washington, United States: the 2 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 28.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | InduPro | InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. | Biotech | Seattle | Series B | $77.0M | 2026-08-12 | $162.0M | Euclidean Capital, The Column Group, Vida Ventures +1 | 51 to 100 | 2022 |
| 2 | Curi Bio | Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. | Artificial intelligence | Seattle | Series B | $10.0M | 2025-12-02 | $30.4M | National Institutes of Health, Dynamk Capital | 11 to 50 | 2015 |
Table 2. Biotech startups that raised Series B in Washington, United States: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator | Boston, United States | 2 | 7% | ||
| 2 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 2 | 7% | ||
| 3 | OrbiMed | Private equity firm | New York, United States | 2 | 7% | ||
| 4 | Keiretsu Capital | Venture capital firm | Seattle, United States | 2 | 7% | ||
| 5 | Euclidean Capital | Family office | New York, United States | 1 | 4% | 1 | InduPro |
| 6 | MRL Ventures Fund | Corporate venture arm | Cambridge, United States | 1 | 4% | 1 | InduPro |
| 7 | Vida Ventures | Venture capital firm | Boston, United States | 1 | 4% | 1 | InduPro |
| 8 | The Column Group | Venture capital firm | San Francisco, United States | 1 | 4% | 1 | InduPro |
| 9 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | 1 | 4% | 1 | Curi Bio |
| 10 | Dynamk Capital | Startup accelerator | New York, United States | 1 | 4% | 1 | Curi Bio |
| 11 | Bristol-Myers Squibb | Venture capital firm | New York, United States | 1 | 4% | ||
| 12 | Abstract | Venture capital firm | San Francisco, United States | 1 | 4% | ||
| 13 | Agent Capital | Venture capital firm | Waltham, United States | 1 | 4% | ||
| 14 | Alumni Ventures | Angel group | Manchester, United States | 1 | 4% | ||
| 15 | iSelect Fund | Private equity firm | St Louis, United States | 1 | 4% |
Table 3. Biotech startups that raised Series B in Washington, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 26 | 93% | $2.0B |
| Software | 4 | 14% | $128.7M |
| Artificial intelligence | 2 | 7% | $56.5M |
| Hardware | 1 | 4% | $26.1M |
Table 4. Biotech startups that raised Series B in Washington, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 28 | 100% | $20.0M |
Table 5. Biotech startups that raised Series B in Washington, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Seattle | 23 | 82% |
| Bothell | 1 | 4% |
| Redmond | 1 | 4% |
| Friday Harbor | 1 | 4% |
| Sammamish | 1 | 4% |
| Kirkland | 1 | 4% |
Table 6. Biotech startups that raised Series B in Washington, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 1 | 50% | $77.0M |
| December 2025 | 1 | 50% | $10.0M |
Table 7. Biotech startups that raised Series B in Washington, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 1 | 4% | $77.0M |
| 2025 | 2 | 7% | $120.0M |
| 2024 | 4 | 14% | $260.6M |
| 2023 | 2 | 7% | $78.9M |
| 2022 | 1 | 4% | $1.8M |
| 2021 | 3 | 11% | $115.0M |
Table 8. Biotech startups that raised Series B in Washington, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 2 | 7% |
| 2015 to 2019 | 12 | 43% |
| 2010 to 2014 | 6 | 21% |
| Before 2010 | 8 | 29% |
Table 9. Biotech startups that raised Series B in Washington, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 7 | 25% |
| 11 to 50 | 14 | 50% |
| 51 to 100 | 3 | 11% |
| 101 to 250 | 2 | 7% |
| 251 to 500 | 1 | 4% |
| 501 to 1,000 | 1 | 4% |
Table 10. Biotech startups that raised Series B in Washington, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in Washington, United States. On 16 November 2026 that is 28 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 2 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 28 rows: 1 have no round amount, 0 no city and 4 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Washington, United States whose last round is Series B are on the list?
- 28, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 28 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.